PYXS · Categories · Form 4

PYXS - SEC Form 4 insider transactions

Pyxis Oncology Inc. (PYXS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PYXS

• 32d
  SEC Form 4 filed by Dupont Jakob

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 32d
  SEC Form 4 filed by Wadhane Jitendra

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 32d
  SEC Form 4 filed by Flavin John L

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 32d
  SEC Form 4 filed by Metzger Michael A

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 32d
  SEC Form 4 filed by Lewis-Hall Freda C

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 32d
  SEC Form 4 filed by Cline Darren S

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 32d
  SEC Form 4 filed by Humphrey Rachel

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 32d
  SEC Form 4 filed by Palani Santhosh

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 32d
  SEC Form 4 filed by Humphrey Rachel

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 80d
  SEC Form 4 filed by Interim CEO Civik Thomas

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by President ,CEO & CMO Sullivan Lara

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Metzger Michael A

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by SVP, Chief Accounting Officer Wadhane Jitendra

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Humphrey Rachel

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Lewis-Hall Freda C

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Cline Darren S

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Palani Santhosh

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Civik Thomas

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by CFO & COO Connealy Pamela Ann

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Flavin John L

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 489d
  SEC Form 4 filed by Chief Executive Officer Sullivan Lara

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 489d
  SEC Form 4 filed by CFO & COO Connealy Pamela Ann

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 489d
  SEC Form 4 filed by SVP, Chief Accounting Officer Wadhane Jitendra

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 685d
  SEC Form 4 filed by Director Metzger Michael A

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 688d
  Palani Santhosh was granted 6,000 shares (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  Flavin John L was granted 35,219 shares, increasing direct ownership by 9% to 413,015 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  SEC Form 4 filed by Sullivan Lara

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  Humphrey Rachel was granted 38,741 shares, increasing direct ownership by 67% to 96,805 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  Cline Darren S was granted 35,219 shares, increasing direct ownership by 16% to 251,405 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  Connealy Pamela Ann was granted 328,710 shares, increasing direct ownership by 42% to 1,110,293 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  Dupont Jakob was granted 38,741 shares (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  Lewis-Hall Freda C was granted 35,219 shares, increasing direct ownership by 17% to 241,405 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  SEC Form 4 filed by Civik Thomas

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 759d
  Wadhane Jitendra was granted 131,484 shares, increasing direct ownership by 49% to 398,421 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 774d
  SEC Form 4 filed by Palani Santhosh

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 849d
  SEC Form 4 filed by Kobayashi Ken

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 878d
  Connealy Pamela Ann covered exercise/tax liability with 36,949 shares, decreasing direct ownership by 5% to 781,583 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 891d
  Wadhane Jitendra was granted 40,000 shares, increasing direct ownership by 18% to 266,937 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 943d
  SEC Form 4 filed by Dupont Jakob

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 951d
  SEC Form 4: Sullivan Lara sold $18,161 worth of shares (8,641 units at $2.10), decreasing direct ownership by 0.36% to 2,403,882 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 956d
  SEC Form 4: Sullivan Lara sold $63,301 worth of shares (27,917 units at $2.27) and covered exercise/tax liability with 184,742 shares, decreasing direct ownership by 8% to 2,412,523 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 961d
  SEC Form 4: Connealy Pamela Ann was granted 187,793 shares, increasing direct ownership by 32% to 782,106 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 961d
  SEC Form 4: Wadhane Jitendra was granted 93,896 shares, increasing direct ownership by 80% to 211,937 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 961d
  SEC Form 4: Sullivan Lara was granted 469,483 shares, increasing direct ownership by 22% to 2,625,182 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 975d
  SEC Form 4 filed by Dupont Jakob

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Sullivan Lara

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Yanchik Connealy Pamela

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Feingold Jay

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Wadhane Jitendra

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Lewis-Hall Freda C

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Humphrey Rachel

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Flavin John L

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Cline Darren S

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1125d
  SEC Form 4 filed by Civik Thomas

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1130d
  SEC Form 4 filed by Pfizer Inc (Amendment)

  4/A - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1132d
  SEC Form 4 filed by Pfizer Inc

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1209d
  SEC Form 4: Sullivan Lara was granted 95,684 shares, increasing direct ownership by 7% to 1,452,320 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1209d
  SEC Form 4: Feingold Jay was granted 53,931 shares, increasing direct ownership by 12% to 520,542 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1209d
  SEC Form 4: Yanchik Connealy Pamela was granted 43,493 shares, increasing direct ownership by 13% to 384,510 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)

Other PYXS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends